Benzyl (S)-2-(((benzyloxy)carbonyl)amino)-4-oxobutanoate, 97%, 100mg

1-Methyleneindane, 95.0%, 5g

3-(5-Oxo-1-phenyl-2-thioxoimidazolidin-4-yl)propanoic acid, 95%, 100mg

1-Chloroethyl isopropyl carbonate, 95.0%, 10g

3-((tert-Butoxycarbonyl)amino)-2,2-dimethylpropanoic acid, 95.0%, 1g

[1-(2-hydroxyethyl)-3,5-dimethyl-1H-pyrazol-4-yl]acetic acid, 95.0%, 500mg

N,3-dimethyl-2-butanamine hydrochloride, 95.0%, 100g

2-(Cyclobutylidenemethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 250mg

Manganese (III) phosphate hydrate, 99.0%, 100g

Methylimidazole, min. 99%, for synthesis, 100 ml, glass packaging

METHYL 3-BROMO-5-FLUORO-4-METHYLBENZOATE, 95.0%, 1g

5-Amino-4-bromopyrimidine, 95.0%, 25g

Hematoxylin solution B acc. to Weigert